BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 12860912)

  • 1. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy.
    Van Driest SL; Ellsworth EG; Ommen SR; Tajik AJ; Gersh BJ; Ackerman MJ
    Circulation; 2003 Jul; 108(4):445-51. PubMed ID: 12860912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.
    Van Driest SL; Ackerman MJ; Ommen SR; Shakur R; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
    Circulation; 2002 Dec; 106(24):3085-90. PubMed ID: 12473556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations.
    Coppini R; Ho CY; Ashley E; Day S; Ferrantini C; Girolami F; Tomberli B; Bardi S; Torricelli F; Cecchi F; Mugelli A; Poggesi C; Tardiff J; Olivotto I
    J Am Coll Cardiol; 2014 Dec; 64(24):2589-2600. PubMed ID: 25524337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
    Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.
    Watkins H; McKenna WJ; Thierfelder L; Suk HJ; Anan R; O'Donoghue A; Spirito P; Matsumori A; Moravec CS; Seidman JG
    N Engl J Med; 1995 Apr; 332(16):1058-64. PubMed ID: 7898523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
    Nakashima Y; Kubo T; Sugiura K; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kimura A; Doi YL; Kitaoka H
    Circ J; 2020 Sep; 84(10):1846-1853. PubMed ID: 32830170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.
    Ackerman MJ; VanDriest SL; Ommen SR; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
    J Am Coll Cardiol; 2002 Jun; 39(12):2042-8. PubMed ID: 12084606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy.
    Nakajima-Taniguchi C; Matsui H; Fujio Y; Nagata S; Kishimoto T; Yamauchi-Takihara K
    J Mol Cell Cardiol; 1997 Feb; 29(2):839-43. PubMed ID: 9140840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.
    Rani DS; Nallari P; Priyamvada S; Narasimhan C; Singh L; Thangaraj K
    BMC Med Genet; 2012 Aug; 13():69. PubMed ID: 22876777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Functional Effects of Cardiomyopathy-Causing Mutations in the Troponin T-Binding Region of Cardiac Tropomyosin.
    Matyushenko AM; Shchepkin DV; Kopylova GV; Popruga KE; Artemova NV; Pivovarova AV; Bershitsky SY; Levitsky DI
    Biochemistry; 2017 Jan; 56(1):250-259. PubMed ID: 27983818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.
    Kimura A; Harada H; Park JE; Nishi H; Satoh M; Takahashi M; Hiroi S; Sasaoka T; Ohbuchi N; Nakamura T; Koyanagi T; Hwang TH; Choo JA; Chung KS; Hasegawa A; Nagai R; Okazaki O; Nakamura H; Matsuzaki M; Sakamoto T; Toshima H; Koga Y; Imaizumi T; Sasazuki T
    Nat Genet; 1997 Aug; 16(4):379-82. PubMed ID: 9241277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
    Bos JM; Poley RN; Ny M; Tester DJ; Xu X; Vatta M; Towbin JA; Gersh BJ; Ommen SR; Ackerman MJ
    Mol Genet Metab; 2006 May; 88(1):78-85. PubMed ID: 16352453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.